James S Blachly, MD
College of Medicine
>Leukemia, Hairy Cell ● Cancer ● Leukemia, Lymphocytic, Chronic, B-Cell ● Infection ● hemorrhage ● Exanthema ● Melanoma ● Carcinoma, Non-Small-Cell Lung ● Thyroid Cancer ● Lung Cancer
Dr. Blachly's interest is in genomics and gene transcription in leukemia and its relevance in experimental therapeutics; namely, whether and how mutations and transcriptional attributes (including gene expression level, but also alternative splicing, alternative polyadenylation, non-protein coding RNAs, etc.) can be studied in the context of clinical trials to provide prognostic and predictive information relevant to novel anticancer therapies.